Topical application of erythropoietin for use in the treatment of corneal lesions

摘要

EPO for use in improving the vision of a patient suffering from an injury or defect of the cornea of the eye or related pathological conditions, in which the patient is administered 20 to 60 units of EPO / kg of Topical body weight / week in the form of aqueous drops, a hydrogel or a liposomal formulation.